Clinical Trials Logo
  1. Home
  2. Crohn's Disease
  3. NCT00862121

A Study With Pentasa in Patients With Active Crohn's Disease — PEACE  

Crohn´s Disease Clinical Trial

Official title:
PENTASA in Active Crohn's Disease: A 10-week, Double-blind, Multi-centre Trial Comparing PENTASA Sachet 6 g/Day (Mesalazine, Mesalamine) With Placebo.

Clinical Trial Summary

The purpose of this trial is to demonstrate that Pentasa administered as a 2 g morning dose and a 4 g evening dose is efficacious in active mild to moderate CD.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00862121
Study type Interventional
Source Ferring Pharmaceuticals
Contact
Status Terminated
Phase Phase 3
Start date April 2009
Completion date October 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT01860651 - Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease N/A
Completed NCT01102855 - Endomicroscopy and Crohn´s Disease N/A
Completed NCT01279577 - Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease Phase 2
Completed NCT01086553 - 9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease Phase 3
Completed NCT02763293 - Osteopathy Non-manipulative in Patients With Crohn's Disease. N/A
Completed NCT01289366 - Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD) N/A
Recruiting NCT06006039 - The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.
Recruiting NCT04022083 - Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease
Completed NCT03890445 - Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease
Completed NCT01564823 - Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease Phase 3
Completed NCT01768858 - Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
Completed NCT01417702 - Endoscopy for Assessment of Mucosal Healing in IBD
Completed NCT01417715 - Endomicroscopy for Assessment of Mucosal Healing